Develops, manufactures and sells products and services for genetic analysis
Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.
It develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets.
Affymetri sells products to some of pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutions.
The company operates through two segments: Affymetrix Core and eBioscience.
The Affymetrix Core segment is divided into three business units, namely Expression, Genetic Analysis and Clinical Applications and Life Science Reagents.
The Expression business unit develops and markets the company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products.
The Genetic Analysis and Clinical Applications business unit develops and markets the company's genotyping, such as the Axiom product line and arrays with clinical research applications, such as the CytoScan cytogenetics arrays.
The Life Science Reagents business unit develops and sells reagents, enzymes, purification kits and biochemical's used by life science researchers.
The eBioscience segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.
It operates in one business unit i.e., Corporate business, which is comprised primarily of revenue from royalty arrangements, and field revenue from services provided to customers by the company.
The company was founded by Stephen P. A. Fodor in 1991 and is headquartered in Santa Clara, CA.